【24h】

Male breast carcinoma.

机译:男性乳腺癌。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To review the epidemiology, presentation, diagnosis, molecular genetics, treatment and prognosis of male breast cancer. DATA SOURCES: Articles, written in English or French, selected from the Medline database (1966 to January 2001), corresponding to the key words "male breast cancer," according to the following criteria: covering institutional experience or comparing diagnostic and treatment modalities, and epidemiologic or general reviews. STUDY SELECTION: Of 198 articles found 50 fulfilled the review criteria. DATA SYNTHESIS: Risk factors included advanced age, a positive family history, Jewish origin, black race, excess exposure to female hormones (Klinefelter's syndrome), environmental exposure (irradiation), alcohol, obesity, higher socioeconomic or higher educational status and childlessness. Gynecomastia remains a controversial factor, this term being used for both a histologic reality and a physical finding. Advanced disease is characterized by pain, bloody discharge and skin ulceration. There is no definitive diagnostic algorithm. Experience with male breast mammography is limited, and imaging is less informative for patients under 50 years of age. Fine-needle aspiration tends to overestimate the rate of malignancy. The commonest histologic finding is infiltrating ductal adenocarcinoma. Treatment includes modified radical mastectomy, followed by cyclophosphamide-methotrexate-5-fluorouracil or 5-fluorouracil-Adriamycin-cyclophosphamide chemotherapy for disease of stage II or greater. Radiotherapy does not seem to add any benefit. The disease is highly receptor-positive; however, many patients discontinue tamoxifen due to side effects. The most important prognostic factors are tumour size, lymphatic invasion and axillary node status. CONCLUSIONS: Because of the low incidence of male breast cancer, advances will be obtained mainly with the rapid transfer of newly gained knowledge in female mammary neoplasia. The increased use of adjuvant chemotherapy combined with tamoxifen postoperatively may have a positive impact on survival. Public education should be oriented toward men at higher risk to reduce the interval between appearance of symptoms and consultation. Rigorous data collection will allow for thorough reporting of risk factors and thus the possibility of characterizing the etiology of this disease.
机译:目的:回顾男性乳腺癌的流行病学,表现,诊断,分子遗传学,治疗和预后。数据来源:根据以下标准,从Medline数据库(1966年至2001年1月)中,以英语或法语撰写的与关键词“男性乳腺癌”相对应的文章:涵盖机构经验或比较诊断和治疗方式,以及流行病学或一般性评论。研究选择:在198篇文章中,有50篇符合审查标准。数据综合:危险因素包括高龄,积极的家族病史,犹太血统,黑人种族,过度暴露于女性荷尔蒙(克莱因费尔特氏综合症),环境暴露(辐射),酒精,肥胖症,较高的社会经济或较高学历和无子女。男性乳房发育症仍然是一个有争议的因素,这个术语既用于组织学上的现实,又用于物理上的发现。晚期疾病的特征在于疼痛,血腥分泌物和皮肤溃疡。没有确定的诊断算法。男性乳房X线摄影的经验有限,对于50岁以下的患者,影像学检查的信息较少。细针穿刺往往会高估恶性肿瘤的发生率。最常见的组织学发现是浸润性导管腺癌。治疗包括改良的根治性乳房切除术,然后治疗II期或更高阶段的疾病的环磷酰胺-甲氨蝶呤-5-氟尿嘧啶或5-氟尿嘧啶-阿霉素-环磷酰胺化疗。放射疗法似乎并没有增加任何益处。这种疾病是高度受体阳性的。然而,由于副作用,许多患者停用他莫昔芬。最重要的预后因素是肿瘤大小,淋巴管浸润和腋窝淋巴结状况。结论:由于男性乳腺癌的发生率低,因此,随着新近获得的女性乳腺肿瘤知识的快速转移,将取得进展。术后辅助化疗与他莫昔芬联合使用的增加可能对生存产生积极影响。公共教育应针对高危男性,以减少症状出现和咨询之间的间隔。严格的数据收集将允许对危险因素进行全面报告,从而有可能表征这种疾病的病因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号